Each 1 m/s increase in estimated pulse wave velocity was associated with a significantly higher risk of all-cause mortality in participants with early-stage CKM syndrome (HR 1.60).
Cohort
Yes
Does estimated pulse wave velocity (ePWV) predict all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome?
9,416 American participants with cardiovascular-kidney-metabolic (CKM) syndrome from NHANES 2007-2018
Estimated pulse wave velocity (ePWV)
CKM syndrome alone (for predictive models) or lower ePWV
All-cause and cardiovascular mortalityhard clinical
Estimated pulse wave velocity (ePWV) is a critical indicator for severity and mortality risk in individuals with CKM syndrome, significantly enhancing mortality risk prediction over CKM syndrome alone.
Abstract Background The impact of estimated pulse wave velocity (ePWV) on the prognosis of cardiovascular-kidney-metabolic (CKM) syndrome has not been explored. This study investigated the association between ePWV and mortality and its predictive performance in individuals with CKM syndrome. Methods This population-based prospective study of 9,416 American participants used ordinal logistic regression to assess the association between ePWV and CKM syndrome severity. Cox regression was applied to evaluate the relationship between ePWV and all-cause and cardiovascular mortality at different CKM stages, as well as their interaction effects on mortality. To evaluate the predictive performance, the area under the curve (AUC) was calculated, and the predictive capabilities of the combined model incorporating both CKM syndrome and ePWV were compared with CKM syndrome alone. Furthermore, various machine learning models were developed for prediction. Results ePWV was found to be significantly associated with the severity of CKM syndrome, with a common odds ratio (cOR) of 1.73 95% confidence interval (CI): 1.68–1.77 per 1 m/s increase in ePWV. Moreover, ePWV demonstrated a significant association with both all-cause and cardiovascular mortality. Specifically, the hazard ratios (HR) per 1 m/s increase in ePWV were: 1.60 95% CI: 1.51–1.69 for all-cause mortality in participants with early-stage CKM, 1.29 95% CI: 1.23–1.35 for all-cause mortality in participants with advanced-stage CKM, 1.84 95% CI: 1.63–2.08 for cardiovascular mortality in participants with early-stage CKM, and 1.23 95% CI: 1.13–1.34 for cardiovascular mortality in participants with advanced-stage CKM. A notable interaction effect between ePWV and CKM syndrome was observed for both all-cause and cardiovascular mortality (P for interaction 0.7). Conclusion ePWV serves as a critical indicator for both the severity and the mortality risk among individuals with CKM syndrome. ePWV significantly enhanced the accuracy of mortality risk prediction of CKM syndrome. Graphical Abstract
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhou et al. (Thu,) conducted a cohort in Cardiovascular-kidney-metabolic (CKM) syndrome (n=9,416). Estimated pulse wave velocity (ePWV) was evaluated on All-cause mortality in participants with early-stage CKM (HR 1.60, 95% CI 1.51-1.69). Each 1 m/s increase in estimated pulse wave velocity was associated with a significantly higher risk of all-cause mortality in participants with early-stage CKM syndrome (HR 1.60).
www.synapsesocial.com/papers/6a080b4ea487c87a6a40d74e — DOI: https://doi.org/10.1186/s13098-026-02174-4
Zhongxing Zhou
Ruming Shen
Jiaxing Ke
Diabetology & Metabolic Syndrome
Fujian Medical University
First Affiliated Hospital of Fujian Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...